GSK

Recent Articles

Prepare for Earnings Season with These 49 Trades

It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 49 trades to consider More 

These 61 Big Blue Chips Are On the Move

During these times it pays to stay on top of the latest profit opportunities. Today's blog post is be a great place to start. Here are our updated rankings More 

Big Trouble for U.S. Stocks in China

Doing business in China can be hazardous to the health of U.S. stocks. Here's a look at just a few of the challenges and risks. More 

The 10 Best Healthcare Stocks to Buy Now

This list of the 10 best healthcare stocks to buy now includes extremely well-capitalized companies paying extraordinary dividends ... and trading for cheap. More 

GSK, BMY: GlaxoSmithKline to Buy Bristol-Myers HIV Drug

GlaxoSmithKline (NYSE:GSK) is buying HIV drugs produced by Bristol-Myers (NYSE:BMY). The Bristol-Myers medication will cost GlaxoSmithKline up to $1.5 billion, making it an even stronger U.K. pharmaceutical giant. The company will shell out $317 million upfront for the drugs, which treat late-stage HIV. An additional $518 million will be paid depending on particular development and... More 

5 Big Pharma Stocks to Buy (And 2 Busts to Avoid!)

Several Big Pharma names are worthy buys right now, but a couple of pharmaceutical stocks may be best left avoided. More 

Nucala: FDA Approves GSK Drug for Severe Asthma

Severe asthma drug Nucala from GlaxoSmithKline (GSK) has been approved by the Food and Drug Administration (FDA). More